ARTA
VBIV

A.R.T. Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

A.R.T. Advisors’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-966
Closed -$90K – 275
2020
Q2 		$90K Buy
966
+574
+146% +$31.6K 0.13% 198
2020
Q1 		$11K Buy
+392
New +$15.2K 0.19% 30
2019
Q3 		– Sell
-722
Closed -$25K – 1783
2019
Q2 		$25K Buy
722
+168
+30% +$9.11K ﹤0.01% 1286
2019
Q1 		$31K Buy
+554
New +$30K ﹤0.01% 1240
2018
Q3 		– Sell
-390
Closed -$32K – 1784
2018
Q2 		$32K Buy
390
+8
+2% +$773 ﹤0.01% 1351
2018
Q1 		$40K Buy
+382
New +$45.6K ﹤0.01% 1416

Other funds holding VBIV

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return